Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Meclizine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of April 1, 2026
    Enforcement Report - Week of April 1, 2026

    01 Apr 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-1-2026-7185.pdf

    FDA
    01 Apr 2026
    Share Share
    Lupin receives approval from US FDA for Meclizine Hydrochloride Tablets USP
    Lupin receives approval from US FDA for Meclizine Hydrochloride Tablets USP

    12 Aug 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/lupin-receives-approval-from-us-fda-for-meclizine-hydrochloride-tablets-usp/

    EXPRESS PHARMA
    12 Aug 2022
    Share Share
    Lupin's Generic Meclizine Hydrochloride Receives Approval in the U.S.
    Lupin's Generic Meclizine Hydrochloride Receives Approval in the U.S.

    11 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203003

    FDA
    11 Aug 2022
    Share Share
    Enforcement Report - Week of April 6, 2022
    Enforcement Report - Week of April 6, 2022

    06 Apr 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-6-2022-1649740823.pdf

    FDA
    06 Apr 2022
    Share Share
    Invagen Pharms' Generic Meclizine Hydrochloride Receives Approval in the U.S.
    Invagen Pharms' Generic Meclizine Hydrochloride Receives Approval in the U.S.

    17 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200432

    FDA
    17 Feb 2022
    Share Share
    Enforcement Report - Week of October 13, 2021
    Enforcement Report - Week of October 13, 2021

    13 Oct 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-13-2021-1634124785.pdf

    FDA
    13 Oct 2021
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.